New positive data for Clovis Oncology’s ovarian cancer treatment Rubraca … plans to submit a supplemental New Drug Application to the FDA within the next … in cancers such as triple-negative breast cancer and prostate cancer.

adminRecentNew positive data for Clovis Oncology's ovarian cancer treatment Rubraca ... plans to submit a supplemental New Drug Application to the FDA within the next ... in cancers such as triple-negative breast cancer and prostate cancer.Breast Cancer Research Updates From Around the Web